1De Boer RA, Yu L, van Veldhuisen DJ. Galectin-3 in cardiac remodeling and heart failure[ J ]. Curr Heart Fail Rep, 2010, 7 ( 1 ) :1 - 8.
2Helming L, Gordon S. Macrophage fusion induced by IL-4 alternative activation is a multistage process involving multiple target molecules[Jl. Eur J lmmunol, 2007, 37( 1 ) :33 -42.
3Henderson NC, Maekinnon AC, Farnworth SL, et al. Galectin-3 expression and secretion links macrophages to the promotion of renal fibrosis[J]. Ant J Pathol, 2008, 172(2) :288 -298.
4Henderson NC, Sethi T. The regulation of inflammation by Galectin- 3[J]. lmmunol Rev, 2009, 230(1 ) :160 - 171.
5MacKinnon AC, Farnworth SL, Hodkinson PS, et al. Regulation of alternative macrophage activation by Galectin-3 [J]. J Immunol, 2008, 180(4) :2650 -2658.
7Thandavarayan RA, Watanabe K, Ma M, et al. 14-3-3 protein regulates Askl signaling and protects against diabetic cardiomyopathy [J]. Biochem Pharmaeol, 2008, 75(9) :1797 -1806.
8de Cavanagh EM, Ferder M, Inserra F, et al. Angiotensin II, mitochondria, cytoskeletal, and extracellular matrix connections: an integrating viewpoint [ J ]. Am J Physiol Heart Circ Physiol, 2009, 296 (3) :H550 - H558.
9Sharma U, Rhaleb NE, Pokharel S, et al. Novel anti-inflammatory mechanisms of N-Acetyl-Scr-Asp-Lys-Pro in hypertensioninduced target organ damage [ J]. Am J Physiol, 2008, 294 ( 3 ) : H1226 - H1232.
1Kido M, Ando K, Onozato ML, et al. Protective effect of dietary potassium against vascular injury in salt-sensitive hypertension[J]. Hypertension, 2008, 51(2):225-231.
2Dorrance AM, Pollock DM, Romanko OP, et al. A high-potassium diet reduces infarct size and improves vascular structure in hypertensive rats[J]. Am J Physiol Regulatory Integrative Comp Physiol, 2007, 292(1):R415-R422.
3Chang HY, Hu YW, Yue CS, et al. Effect of potassium-enriched salt on cardiovascular mortality and medical expenses of elderly men[J]. Am J Clin Nutr, 2006, 83(6):1289-1296.
4Hopkins JW, Lawrence JA, Edgar RM. Potassium loss from blood pressure drugs may explain higher risk of adult diabetes[R/OL]. Science Daily, [2008-11-8]. http://www.sciencedaily.com/releases/2008/11/081124165257.htm.
5Osadchii OE, Bentzen BH, Olesen SP, et al. Chamber-specific effects of hypokalaemia on ventricular arrhythmogenicity in isolated, perfused guinea-pig heart[J]. Experimental Physiology, 2009, 94(4):434-446.
2P. Svensson‐F?rbom,M. Ohlson Andersson,P. Almgren,B. Hedblad,G. Engstr?m,M. Persson,A. Christensson,O. Melander.Cystatin C identifies cardiovascular risk better than creatinine‐based estimates of glomerular filtration in middle‐aged individuals without a history of cardiovascular disease[J]. J Intern Med . 2014 (5)
3Dimitris Tousoulis,Stavroula Michalea,Gerasimos Siasos,Evangelos Oikonomou,Dimitris Athanasiou,Panagiotis Tourikis,Eleni Kokkou,Savvas Mazaris,Theodosia Konsola,Nikolaos Papageorgiou,Christodoulos Stefanadis.Cystatin-C Serum Levels and Vascular Function in Heart Failure[J]. International Journal of Cardiology . 2014
4Shailendra Shailendra Kapoor.Cystatin C and its emerging role in oncology: Clinical benefit beyond its prognostic role in heart failure[J]. European Journal of Internal Medicine . 2013
5Katircibasi Mahmut Tuna,Canatar Taner,Kocum Halil Tolga,Erol Tansel,Tekin Goknur,Demircan Senol,Tekin Abdullah,Sezgin Alpay Turan,Baltali Mehmet,Muderrisoglu Haldun.Decreased heart rate recovery in patients with heart failure: effect of fluvastatin therapy. International heart journal . 2005
6Zamora E,Lupón J,de Antonio M,et al.Long-term prognostic value for patients with chronic heart failure of estimated glomerular filtration rate calculated with the new CKD-EPI equations containing cystatin C. Clinical Chemistry . 2014
7Yamamoto T,Shimano M,Inden Y,et al.Cystatin C as a predictor of mortality and cardiovascular morbidity after cardiac resynchronization therapy. Circulation Journal . 2013
8DjousséL1,Matsumoto C,Petrone A,et al.Plasma galectin 3 and heart failure risk in the Physicians’’Health Study. European Journal of Heart Failure . 2014
9F?ldes Gábor,von Haehling Stephan,Okonko Darlington O,Jankowska Ewa A,Poole-Wilson Philip A,Anker Stefan D.Fluvastatin reduces increased blood monocyte Toll-like receptor 4 expression in whole blood from patients with chronic heart failure. International Journal of Cardiology . 2007
10de Boer RA,Lok DJ,Jaarsma T,et al.Predictive value of plasma ga lectin-3levels in heart failure with reduced and preserved ejection fraction. Annals of Medicine . 2011
